ADVERTISEMENT
MolecuLight Announces Availability of its MolecuLightDX™ Platform on Epic’s App Orchard
MolecuLight Inc. is thrilled to announce the availability of its MolecuLightDX platform on the Epic App Orchard Marketplace and the integration of its platform with Epic’s leading EMR (electronic medical record) platform. Users who use Epic for the treatment of wounds can upload standard, fluorescence, and measurement images captured with the MolecuLightDX device at the point-of-care to the patient’s record. The integrated platforms allow clinicians to optimize their workflow and document their patients’ wounds digitally. The MolecuLightDX application is available on the App Orchard. The MolecuLight i:X and its i:XImaging app are also available on the App Orchard.
Epic and App Orchard are trademarks or registered trademarks of Epic Systems Corporation.
Rob Sandler
Chief Marketing Officer
MolecuLight Inc.
M. +1.416.274.8166
rsandler@moleculight.com
The WoundSource webcast, “When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden? Guidelines based on Delphi Consensus”, is now available online at https://moleculight.com/when-should-i-perform-point-of-care-fluorescence-imaging-of-wound-bioburden/
